Eduardo H. Chuluyan
Buenos Aires, C, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Pathway-driven therapeutic stratification in pancreatic ductal adenocarcinoma.
Journal: Translational oncology
Published: May 11, 2026
Targeting injury-induced transglutaminase-2 activity with a cementoin-SLPI fusion protein: a novel therapeutic strategy for alkali-induced corneal injury.
Journal: Journal of translational medicine
Published: February 23, 2026
Downregulation of the Transglutaminase 2-NF-κB Inflammatory Axis by a Fusion Protein of Cementoin and Secretory Leukocyte Protease Inhibitor Reduces Corneal Angiogenesis.
Journal: International journal of molecular sciences
Published: February 18, 2026
Mechanisms of induced resistance to the antitumoral agent ZZW-115 in pancreas ductal adenocarcinoma.
Mechanisms of induced resistance to the antitumoral agent ZZW-115 in pancreas ductal adenocarcinoma.
Journal: Scientific reports
Published: April 08, 2025
KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma.
Journal: Translational oncology
Published: November 02, 2024
Development of an efficient NUPR1 inhibitor with anticancer activity.
Journal: Scientific reports
Published: May 05, 2024
The mRNA vaccine for the treatment of pancreatic cancer is here to stay
Journal: Medicina
Published: August 15, 2023
LAG3 regulates antibody responses in a murine model of kidney transplantation.
Journal: The Journal of clinical investigation
Published: June 15, 2023
Human Endothelial Cell Seeding in Partially Decellularized Kidneys.
Journal: BioMed research international
Published: March 25, 2022
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity.
Journal: Cancer communications (London, England)
Published: January 26, 2022
Last Updated: 09/26/2026